Skip to content

Drug interactions

Bortezomib + Flibanserin

Severity: Minor

Bortezomib and Flibanserin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bortezomib is a CYP3A4 substrate and not a clinically meaningful CYP3A4 inhibitor, so a pharmacokinetic effect on flibanserin is not expected. Both drugs can cause hypotension and dizziness, which may be additive.

What this interaction means in plain words

Bortezomib and Flibanserin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Bortezomib belongs to Oncology; Flibanserin belongs to Genitourinary.

Evidence level: Low

Why it happens

No established pharmacokinetic mechanism; possible additive hypotensive effects.

What to do

Monitor blood pressure and dizziness in patients on bortezomib who take flibanserin. No dose change is routinely required.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bortezomib and Flibanserin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bortezomib with Flibanserin?

MediHelp rates the interaction as minor. Bortezomib and Flibanserin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Bortezomib is a CYP3A4 substrate and not a clinically meaningful CYP3A4 inhibitor, so a pharmacokinetic effect on flibanserin is not expected. Both drugs can cause hypotension and dizziness, which may be additive.

How serious is the interaction between Bortezomib and Flibanserin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure and dizziness in patients on bortezomib who take flibanserin. No dose change is routinely required.

What other medicines interact with Flibanserin?

MediHelp also lists interactions of Flibanserin with, for example, Atazanavir, Ceritinib, Clarithromycin. The full list is on the Flibanserin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in